[1]
B.V. Girish, Nischal Kundaragi, and K N Puneeth Kumar, “Bleomycin vs Setrol for Sclerotherapy of the Lymphovenous Malformation”, AJMRR, vol. 9, no. 1, pp. 93-98, Jun. 2021.